RUNX1T1 and acute promyelocytic leukemia: Table 1 shows the clinical features of non-APL pediatric patients with AML. Additionally, we found that 13 patients (7.07%), 37 patients (20.11%), 11 patients (5.98%), and 6 patients (3.26%) were positive for the fusion genes CBFβ::MYH11,RUNX1::RUNX1T1, KMT2A::MLLT3, and KMT2A::MLLT10, respectively. The results of the fusion genes are presented in Table 2.